Document:

Exhibit 10.2

    THIS
      AGREEMENT RELATES TO AN OFFERING OF SECURITIES IN AN OFFSHORE TRANSACTION TO
      PERSONS WHO ARE NOT U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE
      SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT")) PURSUANT TO
      REGULATION S UNDER THE SECURITIES ACT. NONE OF THE SECURITIES TO WHICH THIS
      AGREEMENT RELATES HAVE BEEN REGISTERED UNDER THE SECURITIES ACT, OR ANY U.S.
      STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, NONE MAY BE OFFERED OR SOLD,
      DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OR TO U.S. PERSONS (AS DEFINED
      HEREIN) EXCEPT IN ACCORDANCE WITH THE PROVISIONS OF REGULATION S UNDER THE
      SECURITIES ACT, PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE
      SECURITIES ACT, OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION
      NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN
      EACH
      CASE ONLY IN ACCORDANCE WITH ALL APPLICABLE SECURITIES LAWS. IN ADDITION,
      HEDGING TRANSACTIONS INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN
      ACCORDANCE WITH THE SECURITIES ACT.

    

     

    MED-TECH
      SOLUTIONS, INC.

     

    SUBSCRIPTION
      AGREEMENT

     

    SUBSCRIPTION
      AGREEMENT (this “Agreement”) made as of this 26th
      day of
      March, 2007 between Med-Tech Solutions, Inc., a Nevada corporation, (the
“Company”), and the undersigned (the “Subscriber”).

     

    WHEREAS,
      the Company is offering shares
      (the “Shares”) of the Company’s common stock, $0.001 par value (the “Common
      Stock”), to be sold in connection with the proposed private placement (the
      "Private Placement") on a “best efforts” basis, no minimum offering, for a
      maximum offering of up to $2,300,000 in Shares at $0.40 per Share, for up to
      an
      aggregate total of 5,750,000 Shares of Common Stock (the “Offering”). The
      minimum individual subscription is $25,000 (the “Minimum Subscription”), and
      upon the sole election of the Company, the Company may choose to sell a fraction
      of a Minimum Subscription, in increments of $5,000, to any investor who
      purchases or has committed to purchase at least the Minimum
      Subscription;

    

    WHEREAS,
      the Company intends to offer the Shares through the services of its officers,
      directors and agents; 

    

    WHEREAS,
      the offering period (the “PPO
      Period”)
      for
      the Private Placement shall commence on the day the Offering Documents, as
      defined below, are first made available by the Company for delivery in
      connection with the PPO, which is expected to be on or about February 16, 2007
      (the “Delivery
      Date”
or
      the
“Commencement
      Date”)
      and
      shall continue until the earlier to occur of: (i) the sale of all of the Shares;
      (ii) close of business on April 30, 2007 (which period may be extended for
      up to
      an additional 30 days at the sole discretion of the Company) (the “Offering
      Period”); and

    
      
         

        
        

      

      
        
        

        
          

        

      

      
        
        

      

    

    WHEREAS,
      the Subscriber desires to purchase Shares in the amount set forth on the
      signature page hereof on the terms and conditions hereinafter set
      forth.

    

    NOW,
      THEREFORE, in consideration of the premises and the mutual representations
      and
      covenants hereinafter set forth, the parties hereto do hereby agree as
      follows:

    

    I. SUBSCRIPTION
      FOR SECURITIES; REPRESENTATIONS BY AND COVENANTS OF
      SUBSCRIBER

     

    1.1 Subscription
      for Securities.
      Subject
      to the terms and conditions hereinafter set forth and in the Confidential
      Private Placement Memorandum dated February 16, 2007 (such memorandum, together
      with all amendments thereof and supplements and exhibits thereto, the
“Memorandum”), the Subscriber hereby irrevocably subscribes for and agrees to
      purchase from, and the Company agrees to sell to the Subscriber, such number
      of
      Shares which is set forth on the signature page hereof. The entire purchase
      price is due and payable upon the submission of this Subscription Agreement,
      and
      shall be payable by wire transfer or check subject to collection, to the order
      of Sichenzia Ross Friedman Ference LLP, as Escrow Agent. 

    

    The
      wire
      transfer instructions are annexed hereto as Schedule I.

    

    1.2 Reliance
      on Exemptions.
      The
      Subscriber acknowledges that the Offering has not been reviewed by the United
      States Securities and Exchange Commission (the “SEC”) or any state agency
      because it is intended to be an offshore transaction pursuant to Regulation
      S
      (“Regulation S”) as promulgated by the SEC under the Securities Act of 1933, as
      amended. The Subscriber understands that the Company is relying in part upon
      the
      truth and accuracy of, and the Subscriber’s compliance with the representations,
      warranties, agreements, acknowledgments and understandings of the Subscriber
      set
      forth herein in order to determine the availability of such exemptions and
      the
      eligibility of the Subscriber to acquire the Securities.

     

    1.3 Offshore
      Transaction.
      The
      Subscriber agrees that it is acquiring the Securities in an offshore transaction
      pursuant to Regulation S, promulgated under the Securities Act, and hereby
      represents to the Company as follows: 

     

    (a) Subscriber
      is outside the United States when receiving and executing this Subscription
      Agreement; and

    

    (b) Subscriber
      has not acquired the Securities as a result of, and will not itself engage
      in,
      any “directed selling efforts” (as defined in Regulation S under the Securities
      Act) in the United States in respect of the Securities which would include
      any
      activities undertaken for the purpose of, or that could reasonably be expected
      to have the effect of, conditioning the market in the United States for the
      resale of the Securities; provided, however, that the Subscriber may sell or
      otherwise dispose of the Securities pursuant to registration of the Securities
      under the Securities Act and any applicable state and provincial securities
      laws
      or under an exemption from such registration requirements and as otherwise
      provided herein;

    
      
         

        
        

      

      
        2

        
          

        

      

      
        
        

      

    

     

    1.4 Rejection
      of Subscriptions. This
      offering is made subject to withdrawal, cancellation or modification by the
      Company. The Company reserves the right to reject any subscription in whole
      or
      in part or to allot to any prospective Subscriber fewer than the number of
      Shares subscribed for by such Subscriber. Shares will be sold only to a limited
      number of Subscribers meeting certain standards. 

    

    1.5 Compliance
      with U.S. Securities Laws.
      The
      Subscriber agrees that the Company will refuse to register any transfer of
      the
      Securities not made in accordance with the provisions of Regulation S, pursuant
      to an effective registration statement under the Securities Act, or pursuant
      to
      an available exemption from the registration requirements of the Securities
      Act
      and in accordance with applicable state and provincial securities
      laws.

    

    1.6 Distribution
      Compliance Period.
      The
      Subscriber understands and agrees that offers and sales of any of the Securities
      prior to the expiration of a period of one year after the date of transfer
      of
      the Securities under this Subscription Agreement (the “Distribution Compliance
      Period”), shall only be made in compliance with the safe harbor provisions set
      forth in Regulation S, pursuant to the registration provisions of the Securities
      Act or an exemption therefrom, and that all offers and sales after the
      Distribution Compliance Period shall be made only in compliance with the
      registration provisions of the Securities Act or an exemption therefrom, and
      in
      each case only in accordance with all applicable securities laws.

    

    1.7 Hedging
      Transactions.
      The
      Subscriber understands and agrees not to engage in any hedging transactions
      involving the Securities prior to the end of the Distribution Compliance Period
      unless such transactions are in compliance with the Securities Act.

    

    1.8
       Legends.
      The
      Subscriber understands that the certificates representing the Securities, until
      such time as they have been registered under the Securities Act, shall bear
      a
      restrictive legend in substantially the following form (and a stop-transfer
      order may be placed against transfer of such certificates or other
      instruments):

     

    THESE
      SECURITIES WERE ISSUED IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U.S.
      PERSONS (AS DEFINED HEREIN) PURSUANT TO REGULATION S UNDER THE UNITED STATES
      SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”). ACCORDINGLY, NONE OF THE
      SECURITIES TO WHICH THIS CERTIFICATE RELATES HAVE BEEN REGISTERED UNDER THE
      1933
      ACT, OR ANY U.S. STATE SECURITIES LAWS, AND, UNLESS SO REGISTERED, NONE MAY
      BE
      OFFERED OR SOLD IN THE UNITED STATES OR, DIRECTLY OR INDIRECTLY, TO U.S. PERSONS
      (AS DEFINED HEREIN) EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT
      OR
      PURSUANT TO AN EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE
      REGISTRATION REQUIREMENTS OF THE 1933 ACT AND IN EACH CASE ONLY IN ACCORDANCE
      WITH APPLICABLE STATE SECURITIES LAWS. IN ADDITION, HEDGING TRANSACTIONS
      INVOLVING THE SECURITIES MAY NOT BE CONDUCTED UNLESS IN ACCORDANCE WITH THE
      1933
      ACT.

    

    The
      legend set forth above shall be removed and the Company shall issue a
      certificate without such legend to the holder of the Securities upon which
      it is
      stamped, if (a)

     

    
      
         

        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    such
      Securities are being sold pursuant to a registration statement under the
      Securities Act, or (b) such holder delivers to the Company an opinion of
      counsel, in a reasonably acceptable form, to the Company that a disposition
      of
      the Securities is being made pursuant to an exemption from such
      registration.

     

    1.9 Risk
      of Investment.
      The
      Subscriber recognizes that the purchase of the Securities involves a high degree
      of risk in that: (a) an investment in the Company is highly speculative and
      only
      investors who can afford the loss of their entire investment should consider
      investing in the Company and the Securities; (b) transferability of the
      Securities is limited; and (c) the Company may require substantial additional
      funds to operate its business and subsequent equity financings will dilute
      the
      ownership and voting interests of Subscriber.

     

    1.10 Information.
      The
      Subscriber acknowledges careful review of this Subscription Agreement, the
      Memorandum, as well as the Company’s filings with the Securities and Exchange
      Commission, as required pursuant to the Securities and Exchange Act of 1934,
      which are available on the Internet at www.sec.gov
      (collectively, the “Offering Documents”), all of which the undersigned
      acknowledges have been provided to the undersigned. The undersigned has been
      given the opportunity to ask questions of, and receive answers from, the Company
      concerning the terms and conditions of this Offering and the Offering Documents
      and to obtain such additional information, to the extent the Company possesses
      such information or can acquire it without unreasonable effort or expense,
      necessary to verify the accuracy of same as the undersigned reasonably desires
      in order to evaluate the investment. The undersigned understands the Offering
      Documents, and the undersigned has had the opportunity to discuss any questions
      regarding any of the Offering Documents with its counsel or other advisor.
      Notwithstanding the foregoing, the only information upon which the undersigned
      has relied is that set forth in the Offering Documents. The undersigned has
      received no representations or warranties from the Company, its employees,
      agents or attorneys in making this investment decision other than as set forth
      in the Offering Documents. The undersigned does not desire to receive any
      further information.

    

    1.11 No
      Representations.
      The
      Subscriber hereby represents that, except as expressly set forth in the Offering
      Documents, no representations or warranties have been made to the Subscriber
      by
      the Company or any agent, employee or affiliate of the Company, and in entering
      into this transaction the Subscriber is not relying on any information other
      than that contained in the Offering Documents and the results of independent
      investigation by the Subscriber.

    

    1.12 Tax
      Consequences.
      The
      Subscriber acknowledges that the Offering may involve tax consequences and
      that
      the contents of the Offering Documents do not contain tax advice or information.
      The Subscriber acknowledges that it must retain its own professional advisors
      to
      evaluate the tax and other consequences of an investment in the
      Securities.

     

    1.13 Transfer
      or Resale.
      The
      Subscriber understands and hereby acknowledges that the Company is under no
      obligation to register the Securities under the Securities Act except as
      contained herein. The Subscriber consents that the Company may, if it desires,
      permit the transfer of the Securities out of the Subscriber’s name only when the
      Subscriber’s request for transfer is accompanied by an opinion of counsel
      reasonably satisfactory to the Company that neither the sale nor the proposed
      transfer results in a violation of the Securities Act or any applicable state
      “blue sky” laws.

     

    
      
         

        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

     

    1.14 Validity;
      Enforcement.
      If the
      Subscriber is a corporation, partnership, trust or other entity, the Subscriber
      represents and warrants that: (a) it is authorized and otherwise duly qualified
      to purchase and hold the Securities; and (b) that this Subscription Agreement
      has been duly and validly authorized, executed and delivered and constitutes
      the
      legal, binding and enforceable obligation of the undersigned. If the Subscriber
      is an individual, the Subscriber represents and warrants that this Subscription
      Agreement has been duly and validly executed and delivered and constitutes
      the
      legal, binding and enforceable obligation of the undersigned.

     

    1.15 Address.
      The
      Subscriber hereby represents that the address of the Subscriber furnished by
      the
      Subscriber at the end of this Subscription Agreement is the undersigned’s
      principal residence if the Subscriber is an individual or its principal business
      address if it is a corporation or other entity.

     

    1.16 Foreign
      Subscriber.
      The
      Subscriber hereby represents that it has satisfied itself as to the full
      observance of the laws of its jurisdiction in connection with any invitation
      to
      subscribe for the Securities or any use of this Subscription Agreement,
      including: (a) the legal requirements within its jurisdiction for the purchase
      of the Securities; (b) any foreign exchange restrictions applicable to such
      purchase; (c) any governmental or other consents that may need to be obtained;
      and (d) the income tax and other tax consequences, if any, that may be relevant
      to the purchase, holding, redemption, sale or transfer of the Securities. Such
      Subscriber’s subscription and payment for, and its continued beneficial
      ownership of the Securities, will not violate any applicable securities or
      other
      laws of the Subscriber’s jurisdiction.

     

    1.17 Closing
      Conditions.
      The
      Subscriber understands and hereby acknowledges that:

     

    1.17.1 Pursuant
      to the terms of the Heads of Agreement dated February 8, 2007, entered into
      by
      and between the Company and The Four Rivers BioEthanol Company Limited (“4Rivers
      Limited”), a copy of which is annexed as Exhibit C to the Memorandum, the
      closing conditions of this Offering (the “Closing Conditions”), include, but are
      not limited to (i) negotiation and execution of a definitive Acquisition
      Agreement to be entered into by and among the Company, The Four Rivers BioEnergy
      Company, a company to be formed and registered under the laws of the State
      of
      Kentucky (or a similarly named Kentucky corporation) (“4Rivers”), which shall be
      the parent of 4Rivers Limited and all of the shareholders of 4Rivers, (ii)
      the
      Company successfully raising the Initial Funding, (iii) compliance with US
      and
      EU securities, corporate and other applicable laws, (iv) satisfaction of
      conditions precedent set forth in Part I of Attachment A to the Letter of
      Intent, a copy of which is annexed as Exhibit C to the Memorandum, and (v)
      completion of all of these Closing Conditions within the contemplated timeframe,
      subject to the parties mutual agreement to extend such.

     

    1.17.2 Moreover,
      after the closing of this Offering, subject to obtaining Shareholder Approval
      (as defined below), the Company intends to effect a 10-for-1

     

    
      
         

        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    reverse
      stock split of all of its issued and outstanding common stock (the “Reverse
      Split”), and (ii) subsequent to the Reverse Split, the Company further intends
      to effect a 7 for 1 dividend in kind (the “Dividend”). Furthermore, certain of
      its current shareholders have agreed, subsequent to the Reverse Split and the
      Dividend, to retire portions of their holdings in order to result in the equity
      structure set forth as Attachment B to the Heads of Agreement (the “Retirement
      of Stock”). As a result, the issued and outstanding amount of the shares of the
      Company’s Common Stock (i) after the closing of this Offering, (ii) subsequent
      to the Reverse Split, Dividend and Retirement of Stock being effected, and
      (iii)
      before the Main Acquisition is completed as contemplated by the Heads of
      Agreement, if at all, shall be approximately 44,600,000. Furthermore, as
      contemplated by the Heads of Agreement, in the event we are successful in our
      acquisition of 4Rivers, we intend to issue 40,665,000 shares of our Common
      Stock
      to shareholders of 4Rivers. “Shareholder Approval” shall mean the approval of
      our shareholders holding at least the majority of our then issued and
      outstanding shares of Common Stock to permit us to effect a 10-for-1 reverse
      stock split of all of our issued and outstanding common stock.

     

    1.17.3
      The closing of this Offering is conditional on the execution of the Acquisition
      Agreement and the execution of the Acquisition Agreement (i) is conditional
      on
      the successful closing of this Offering, (ii) shall take place simultaneously
      with the closing of this Offering, and (iii) is a closing condition of this
      Offering. 

     

    The
      Company cannot provide any guarantee that the Closing Conditions will be
      satisfied or that it will be successful in its efforts to complete the Main
      Funding. 

     

    1.18
       Lock-up
      Period.
      The
      Subscriber understands and agrees that the Subcriber will not sell the Shares
      for a period of twelve months from the date of the Subscriber’s purchase, unless
      permitted earlier by the Company. Notwithstanding the foregoing, by purchasing
      the Shares the Subscriber agrees to be bound by any lock-up period required
      by
      state regulatory agencies or any other governmental regulation, including but
      not limited, to those distribution limitations set forth in Section 1.6 of
      this
      Agreement.

     

    II. REPRESENTATIONS
      BY THE COMPANY

     

    The
      Company represents and warrants to the Subscriber, except as set forth in the
      disclosure schedules attached hereto:

     

    2.1 Organization,
      Good Standing and Qualification. The
      Company is a corporation duly organized, validly existing and in good standing
      under the laws of the State of Nevada and has full corporate power and authority
      to conduct its business.

    

    2.2 Capitalization
      and Voting Rights.
      The
      authorized, issued and outstanding capital stock of the Company is as set forth
      in the Company’s Annual Report filed on Form 10-KSB with the SEC on February 13,
      2007, and all issued and outstanding shares of the Company are validly issued,
      fully paid and nonassessable. Except as set forth in the Offering Documents
      and
      the Company’s SEC filings, there are no outstanding options, warrants,
      agreements, convertible securities, preemptive rights or other rights to
      subscribe for or to purchase any shares of capital stock of the Company. Except
      as set forth in the Offering Documents
      and the Company’s SEC filings, and as otherwise required by law, there are no
      restrictions upon the voting or transfer of any of the shares of capital stock
      of the Company pursuant to the Company’s Articles of Incorporation (the
“Articles of Incorporation”), By-Laws or other governing documents or any
      agreement or other instruments to which the Company is a party or by which
      the
      Company is bound.

    
      
         

        
        

      

      
        6

        
          

        

      

      
        
        

      

    

    Documents
      and the Company’s SEC filings, and as otherwise required by law, there are no
      restrictions upon the voting or transfer of any of the shares of capital stock
      of the Company pursuant to the Company’s Articles of Incorporation (the
“Articles of Incorporation”), By-Laws or other governing documents or any
      agreement or other instruments to which the Company is a party or by which
      the
      Company is bound.

    

    2.3 Authorization;
      Enforceability. The
      Company has all corporate right, power and authority to enter into this
      Agreement and to consummate the transactions contemplated hereby. All corporate
      action on the part of the Company, its directors and stockholders necessary
      for
      the (i) authorization execution, delivery and performance of this Agreement
      by
      the Company; and (ii) authorization, sale, issuance and delivery of the
      Securities contemplated hereby and the performance of the Company’s obligations
      hereunder has been taken. This Agreement has been duly executed and delivered
      by
      the Company and constitutes a legal, valid and binding obligation of the
      Company, enforceable against the Company in accordance with its terms, subject
      to laws of general application relating to bankruptcy, insolvency and the relief
      of debtors and rules of law governing specific performance, injunctive relief
      or
      other equitable remedies, and to limitations of public policy. The Common Stock,
      when issued and fully paid for in accordance with the terms of this Agreement,
      will be validly issued, fully paid and nonassessable. The issuance and sale
      of
      the Shares of Common Stock contemplated hereby will not give rise to any
      preemptive rights or rights of first refusal on behalf of any person which
      have
      not been waived in connection with this offering.

    

    2.4 No
      Conflict; Governmental Consents.

    

    (a) The
      execution and delivery by the Company of this Agreement and the consummation
      of
      the transactions contemplated hereby will not result in the violation of any
      material law, statute, rule, regulation, order, writ, injunction, judgment
      or
      decree of any court or governmental authority to or by which the Company is
      bound, or of any provision of the Articles of Incorporation or By-Laws of the
      Company, and will not conflict with, or result in a material breach or violation
      of, any of the terms or provisions of, or constitute (with due notice or lapse
      of time or both) a default under, any lease, loan agreement, mortgage, security
      agreement, trust indenture or other agreement or instrument to which the Company
      is a party or by which it is bound or to which any of its properties or assets
      is subject, nor result in the creation or imposition of any lien upon any of
      the
      properties or assets of the Company.

    

    (b) No
      consent, approval, authorization or other order of any governmental authority
      is
      required to be obtained by the Company in connection with the authorization,
      execution and delivery of this Agreement or with the authorization, issue and
      sale of the Shares, except such filings as may be required to be made with
      the
      SEC, NASD, NASDAQ and with any state or foreign blue sky or securities
      regulatory authority.

    

    2.5 Licenses.
      Except
      as otherwise set forth in the Memorandum, the Company has sufficient licenses,
      permits and other governmental authorizations currently required for the conduct
      of its business or ownership of properties and is in all material respects
      in
      compliance therewith.

    
      
         

        
        

      

      
        7

        
          

        

      

      
        
        

      

    

    2.6 Litigation.  Except
      as
      may be disclosed in the Offering Documents and the Company’s SEC filings, the
      Company knows of no pending or threatened legal or governmental proceedings
      against the Company which could materially adversely affect the business,
      property, financial condition or operations of the Company or which materially
      and adversely questions the validity of this Agreement or any agreements related
      to the transactions contemplated hereby or the right of the Company to enter
      into any of such agreements, or to consummate the transactions contemplated
      hereby or thereby. The Company is not a party or subject to the provisions
      of
      any order, writ, injunction, judgment or decree of any court or government
      agency or instrumentality which could materially adversely affect the business,
      property, financial condition or operations of the Company. There is no action,
      suit, proceeding or investigation by the Company currently pending in any court
      or before any arbitrator or that the Company intends to initiate.

    

    2.7 Disclosure.
      The
      information set forth in the Offering Documents as of the date hereof contains
      no untrue statement of a material fact nor omits to state a material fact
      necessary in order to make the statements contained therein, in light of the
      circumstances under which they were made, not misleading.

    

    2.8 Investment
      Company.
      The
      Company is not an “investment company” within the meaning of such term under the
      Investment Company Act of 1940, as amended, and the rules and regulations of
      the
      SEC thereunder.

    

    2.9 Intellectual
      Property.

    

    (a) To
      the
      best of its knowledge, the Company owns or possesses sufficient legal rights
      to
      all patents, trademarks, service marks, trade names, copyrights, trade secrets,
      licenses, information and other proprietary rights and processes necessary
      for
      its business as now conducted and as presently proposed to be conducted, without
      any known infringement of the rights of others. Except as disclosed in the
      Memorandum, there are no material outstanding options, licenses or agreements
      of
      any kind relating to the foregoing proprietary rights, nor is the Company bound
      by or a party to any material options, licenses or agreements of any kind with
      respect to the patents, trademarks, service marks, trade names, copyrights,
      trade secrets, licenses, information and other proprietary rights and processes
      of any other person or entity other than such licenses or agreements arising
      from the purchase of “off the shelf” or standard products. The Company has not
      received any written communications alleging that the Company has violated
      or,
      by conducting its business as presently proposed to be conducted, would violate
      any of the patents, trademarks, service marks, trade names, copyrights or trade
      secrets or other proprietary rights of any other person or entity. 

    

    (b) Except
      as
      disclosed in the Memorandum, the Company is not aware that any of its employees
      is obligated under any contract (including licenses, covenants or commitments
      of
      any nature) or other agreement, or subject to any judgment, decree or order
      of
      any court or administrative agency, that would interfere with their duties
      to
      the Company or that would conflict with the Company’s business as presently
      conducted. 

    
      
         

        
        

      

      
        8

        
          

        

      

      
        
        

      

    

    (c) Neither
      the execution nor delivery of this Agreement, nor the carrying on of the
      Company’s business by the employees of the Company, nor the conduct of the
      Company’s business as presently conducted, will, to the Company’s knowledge,
      conflict with or result in a breach of the terms, conditions or provisions
      of,
      or constitute a default under, any contract, covenant or instrument under which
      any employee is now obligated.

    

    (d) To
      the
      Company’s knowledge, no employee of the Company, nor any consultant with whom
      the Company has contracted, is in violation of any term of any employment
      contract, proprietary information agreement or any other agreement relating
      to
      the right of any such individual to be employed by, or to contract with, the
      Company because of the nature of the business conducted by the Company; and
      to
      the Company’s knowledge the continued employment by the Company of its present
      employees, and the performance of the Company’s contracts with its independent
      contractors, will not result in any such violation. The Company has not received
      any written notice alleging that any such violation has occurred. Except as
      described in the Memorandum, no employee of the Company has been granted the
      right to continued employment by the Company or to any compensation following
      termination of employment with the Company except for any of the same which
      would not have a material adverse effect on the business of the Company. The
      Company is not aware that any officer, key employee or group of employees
      intends to terminate his, her or their employment with the Company, nor does
      the
      Company have a present intention to terminate the employment of any officer,
      key
      employee or group of employees.

    

    2.10
       Title
      to Properties and Assets; Liens, Etc.
      The
      Company has good and marketable title to its properties and assets, including
      the properties and assets reflected in the most recent balance sheet included
      in
      the Financial Statements, and good title to its leasehold estates, in each
      case
      subject to no mortgage, pledge, lien, lease, encumbrance or charge, other than
      (a) those resulting from taxes which have not yet become delinquent; (b) liens
      and encumbrances which do not materially detract from the value of the property
      subject thereto or materially impair the operations of the Company; and (c)
      those that have otherwise arisen in the ordinary course of business. The Company
      is in compliance with all material terms of each lease to which it is a party
      or
      is otherwise bound.

    

    2.11 Obligations
      to Related Parties.
      Except
      as described in the Memorandum, there are no obligations of the Company to
      officers, directors, stockholders, or employees of the Company other than (a)
      for payment of salary or other compensation for services rendered, (b)
      reimbursement for reasonable expenses incurred on behalf of the Company and
      (c)
      for other standard employee benefits made generally available to all employees
      (including stock option agreements outstanding under any stock option plan
      approved by the Board of Directors of the Company). Except as may be disclosed
      in the Memorandum, the Company is not a guarantor or indemnitor of any
      indebtedness of any other person, firm or corporation.

    

    2.12 Failure
      to Satisfy the Closing Conditions. In
      the
      event the Closing Conditions, as defined in the Memorandum and set forth in
      Section 1.17 of this Agreement, are not satisfied during the Offering Period
      (subject to applicable extensions), the Escrow Agent shall receive written
      notice executed by a duly authorized executive officer of the Company indicating
      that this Offering has been terminated and designating a termination date,
      and
      shall return to each Subscriber, all funds received from such Subscriber,
      pursuant to this Offering (without interest or deduction) and all documents
      delivered by such Subscriber to the Escrow Agent. 

    
      
        
        

      

      
        9

        
          

        

      

      
        
        

      

    

     

     

    III.
       MISCELLANEOUS

    

    3.1 Notice.
      Any
      notices, consents, waivers or other communications required or permitted to
      be
      given under the terms of this Subscription Agreement must be in writing and
      will
      be deemed to have been delivered: (a) upon receipt, when delivered personally,
      (b) upon receipt, when sent by facsimile (provided confirmation of transmission
      is mechanically or electronically generated and kept on file by the sending
      party), or (c) one (1) business day after deposit with an overnight courier
      service, in each case properly addressed to the party to receive the same.
      The
      addresses and facsimile numbers for such communications shall be:

     

    If
      to the
      Company:

    

    Med-Tech
      Solutions, Inc.

    Suite
      2200 - 1177 West Hastings Street

    Vancouver,
      British Columbia, Canada V6E 2K3

    Attn:
       Mark
      A.
      McLeary

    Facsimile:
      (604) 688-7526

    

    With
      a
      copy to (which shall not constitute notice):

    

    Sichenzia
      Ross Friedman Ference LLP

    1065
      Avenue of the Americas

    New
      York,
      NY 10018

    Attn:
       Richard
      A. Friedman, Esq

    Facsimile:
      (212) 930-9725

    

    If
      to the
      Subscriber, to its address and facsimile number set forth at the end of this
      Subscription Agreement, or to such other address and/or facsimile number and/or
      to the attention of such other person as specified by written notice given
      to
      the Company five (5) days prior to the effectiveness of such change. Written
      confirmation of receipt (a) given by the recipient of such notice, consent,
      waiver or other communication, (b) mechanically or electronically generated
      by
      the sender’s facsimile machine containing the time, date, recipient facsimile
      number and an image of the first page of such transmission, or (c) provided
      by
      an overnight courier service shall be rebuttable evidence of personal service,
      receipt by facsimile or receipt from an overnight courier service in accordance
      with clause (a), (b) or (c) above, respectively.

     

    3.2 Entire
      Agreement; Amendment.
      This
      Subscription Agreement supersedes all other prior oral or written agreements
      between the Subscriber, the Company, their affiliates and persons acting on
      their behalf with respect to the matters discussed herein, and this Subscription
      Agreement and the instruments referenced herein contain the entire understanding
      of the parties with respect to the matters covered herein and therein and,
      except as specifically set forth herein or therein, neither the Company nor
      the
      Subscriber makes any representation, warranty, covenant or undertaking with
      respect to such matters. No provision of this Subscription Agreement may be
      amended or waived other than by an instrument in writing signed by the Company
      and the holders of at least a majority of the Securities then outstanding
      (determined on an as exercised to common stock basis) (or if prior to the
      closing, the Subscribers purchasing at least a majority of the Securities to
      be
      purchased at the closing). No such amendment shall be effective to the extent
      that it applies to less than all of the holders of the Securities then
      outstanding.

     

    
      
         

        
        

      

      
        10

        
          

        

      

      
        
        

      

    

     

     

    3.3 Severability.
      If any
      provision of this Subscription Agreement shall be invalid or unenforceable
      in
      any jurisdiction, such invalidity or unenforceability shall not affect the
      validity or enforceability of the remainder of this Subscription Agreement
      in
      that jurisdiction or the validity or enforceability of any provision of this
      Subscription Agreement in any other jurisdiction.

     

    3.4 Governing
      Law; Jurisdiction; Waiver of Jury Trial.
      This
      Agreement shall be governed by, and construed in accordance with the laws of
      the
      State of New York without regard to the choice of law principles thereof. Each
      of the parties hereto irrevocably submits to the exclusive jurisdiction of
      the
      courts of the State of New York for the purpose of any suit, action, proceeding
      or judgment relating to or arising out of this Agreement and the transactions
      contemplated hereby. Service of process in connection with any such suit, action
      or proceeding may be served on each party hereto anywhere in the world by the
      same methods as are specified for the giving of notices under this Agreement.
      Each of the parties hereto irrevocably consents to the jurisdiction of any
      such
      court in any such suit, action or proceeding and to the laying of venue in
      such
      court. Each party hereto irrevocably waives any objection to the laying of
      venue
      of any such suit, action or proceeding brought in such courts and irrevocably
      waives any claim that any such suit, action or proceeding brought in any such
      court has been brought in an inconvenient forum. EACH OF THE PARTIES HERETO
      WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT
      TO
      THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY
      AS TO
      THIS WAIVER.

    

    3.5 Headings.
      The
      headings of this Subscription Agreement are for convenience of reference and
      shall not form part of, or affect the interpretation of, this Subscription
      Agreement.

    

    3.6 Successors
      And Assigns.
      This
      Subscription Agreement shall be binding upon and inure to the benefit of the
      parties and their respective successors and assigns. The Company shall not
      assign this Subscription Agreement or any rights or obligations hereunder
      without the prior written consent of the holders of at least a majority the
      Securities then outstanding, except by merger or consolidation. The Subscriber
      shall not assign its rights hereunder without the consent of the Company, which
      consent shall not be unreasonably withheld.

    
      
        
        

      

      
        11

        
          

        

      

      
        
        

      

    

    3.7 No
      Third Party Beneficiaries.
      This
      Subscription Agreement is intended for the benefit of the parties hereto and
      their respective permitted successors and assigns, and is not for the benefit
      of, nor may any provision hereof be enforced by, any other person.

    3.8 Survival.
      The
      representations and warranties of the Company and the Subscriber contained
      in
      Articles I and II and the agreements set forth this Article IV shall survive
      closing for a period of two years.

     

    3.9 Further
      Assurances.
      Each
      party shall do and perform, or cause to be done and performed, all such further
      acts and things, and shall execute and deliver all such other agreements,
      certificates, instruments and documents, as the other party may reasonably
      request in order to carry out the intent and accomplish the purposes of this
      Subscription Agreement and the consummation of the transactions contemplated
      hereby.

     

    3.10 No
      Strict Construction.
      The
      language used in this Subscription Agreement will be deemed to be the language
      chosen by the parties to express their mutual intent, and no rules of strict
      construction will be applied against any party.

     

    3.11 Legal
      Effect.
      The
      Subscriber acknowledges that: (a) it has read this Subscription Agreement and
      the exhibits hereto; and (b) it understands the terms and consequences of this
      Subscription Agreement and is fully aware of its legal and binding
      effect.

     

    3.12 Counterparts.
      This
      Subscription Agreement may be executed in two or more identical counterparts,
      all of which shall be considered one and the same agreement and shall become
      effective when counterparts have been signed by each party and delivered to
      the
      other party; provided that a facsimile signature shall be considered due
      execution and shall be binding upon the signatory thereto with the same force
      and effect as if the signature were an original, not a facsimile
      signature.

     

    [Signature
      page follows.]

     

    

     

    

     

    

     

    

     

    
      
         

        
        

      

      
        12

        
          

        

      

      
        
        

      

    

    IN
      WITNESS WHEREOF, the parties have executed this Subscription Agreement as of
      the
      day and year first written above.

     

    

     

    
      	
              ______________________________________

              Name
                of Subscriber

            	
              No.
                of Shares:
                

              _________________________

            
	
               

              ______________________________________

              Signature

            
	
               

              ______________________________________

              Name
                (Please Print)

            

    

     

    ______________________________________

    Title

    

     

     ______________________________________

    Address
      of Subscriber

    

     

     ______________________________________

    Taxpayer
      Identification Number of Subscriber

    

    

    

    

    

    

    Subscription
      Aceepted:

     

    
      	 	 	 
	 	MED-TECH SOLUTIONS, INC.
	 
 	 
 	 
 
	 	By:  	/s/ Mark
              A.
              McLeary
	 	
              
Name:
              Mark A. McLeary
	 	Title:
              Chief Executive Officer

    

    

     

     

    

    

    
      
        
 

        
        

      

      
        13

        
          

        

      

      
        
        

      

    

    SCHEDULE
      I

    Escrow
      Agent Wire Instructions

     

    The
      wire
      transfer instructions are as follows:

    

    BANK:
        Citibank

    New
      York,
      NY 

    A/C
      of
      Sichenzia Ross Friedman Ference LLP, IOLA

    

    ABA:
         

    ACCOUNT:
        

    SWIFT
      Code:  

    REFERENCE:
       “Med-Tech
      Solutions, Inc. - [insert Subscriber’s name]”

     

     

    Sichenzia
      Ross Friedman Ference LLP Accounting Contact: Mimi Shore; telephone: (212)
      930-9700; email: mshore@srff.com.Exhibit 10.3

    ESCROW
      AGREEMENT

     

    THIS
      ESCROW AGREEMENT (this “Agreement”)
      is
      made as of March 26, 2007, by and among Med-Tech Solutions, Inc., a Nevada
      corporation (the “Company”),
      the
      purchasers signatories hereto (each a “Purchaser”
and
      together the “Purchasers”),
      and
      Sichenzia Ross Friedman Ference LLP, with an address at 1065 Avenue of the
      Americas, New York, New York 10036 (the “Escrow
      Agent”).
      Capitalized
      terms used but not defined herein shall have the meanings set forth in the
      Subscription Agreement and the Confidential Private Placement Memorandum
      referred to in the first recital.

     

    W
      I T N E
      S S E T H:

     

    WHEREAS,
      the Purchasers will be purchasing from the Company in a private placement
      transaction, severally and not jointly with the other Purchasers, in the
      aggregate, up to $2,300,000.00 of Shares of Common Stock of the Company on
      the
      Closing Date as set forth in the Subscription Agreement (the “Subscription
      Agreement”)
      dated
      the date hereof between the Purchasers and the Company and the Confidential
      Private Placement Memorandum dated February 16, 2007, which securities will
      be
      issued under the terms contained herein and in the Subscription Agreement;
      and

     

    WHEREAS,
      the Offering is being made to “accredited investors”, as defined in Regulation D
      under the Securities Act of 1933, as amended (the “1933 Act”), in accordance
      with Regulation S of the 1933 Act on a “best efforts”, no minimum, $2,300,000
      maximum offering basis; 

     

    WHEREAS,
      the minimum subscription amount that will be accepted from any investor is
      $25,000; 

     

    WHEREAS,
      the closing of the Offering is conditioned on the receipt of acceptable
      subscriptions for the Shares (the requirement for the receipt of acceptable
      subscription, together with certain other conditions to closing, are
      collectively referred to as the “Closing Conditions”); 

     

    WHEREAS,
      the Offering will commence on or about February 16, 2007 and will close only
      after the satisfaction of all Closing Conditions, but must lose on or prior
      to
      April 30, 2007, which date may be extended for up to an additional 30 days
      at
      the sole discretion of the Company (the “Closing Date”); 

     

    WHEREAS,
      the Company and the Purchasers have requested that the Escrow Agent hold the
      Subscription Amounts in escrow upon the terms set forth herein;

    

    NOW,
      THEREFORE, in consideration of the covenants and mutual promises contained
      herein and other good and valuable consideration, the receipt and legal
      sufficiency of which are hereby acknowledged and intending to be legally bound
      hereby, the parties agree as follows:

     

    
      
         

        
        

      

      
        
          

        

      

      
        
        

      

    

    ARTICLE
      1

     

    TERMS
      OF
      THE ESCROW

     

    1.1. The
      parties hereby agree to establish an escrow account with the Escrow Agent
      whereby the Escrow Agent shall hold the funds for the purchase of up to
      $2,300,000.00 in the aggregate, of Shares as contemplated by the Subscription
      Agreement.

     

    1.2. Upon
      the
      Escrow Agent’s receipt of the aggregate Subscription Amounts for the Closing
      into its master escrow account, together with executed counterparts of this
      Agreement, the Subscription Agreement and the completed Confidential Prospective
      Purchaser Questionnaire, it shall within one business day telephonically advise
      the Company, or the Company’s designated attorney or agent and counsel of the
      Purchasers, of the amount of funds it has received into its master escrow
      account.

     

    1.3. Wire
      transfers to the Escrow Agent shall be made as follows:

     

    BANK:
        Citibank

    New
      York,
      NY 

    A/C
      of
      Sichenzia Ross Friedman Ference LLP, IOLA

    

    ABA:  

    ACCOUNT: 

    SWIFT
      Code: CITIUS33

    REFERENCE:
       “Med-Tech
      Solutions, Inc. - [insert Purchaser’s name]”

     

     

    Sichenzia
      Ross Friedman Ference LLP Accounting Contact: Mimi Shore; telephone: (212)
      930-9700; email: mshore@srff.com.

     

    1.4 The
      Company, promptly following being advised by the Escrow Agent that the Escrow
      Agent has received the Subscription Amounts for the Closing along with facsimile
      copies of counterpart signature pages of the Subscription Agreement,
      Confidential Prospective Purchaser Questionnaire and this Agreement from each
      Purchaser, and 4Rivers’ executed counterpart of the Acquisition Agreement, shall
      deliver to the Escrow Agent for the Closing the Shares to be issued to each
      Purchaser at the Closing together with:

     

    (a) the
      Company’s executed counterpart of the Subscription Agreement;

    

    (b) the
      Company’s original executed counterpart of this Escrow Agreement; 

    

    (c) the
      Company’s original executed counterpart of the Acquisition Agreement;

    

    (d) the
      deliverables as per the Subscription Agreement.

    

    1.5 In
      the
      event that the foregoing items are not in the Escrow Agent’s possession within
      five (5) Business Days of the Escrow Agent notifying the Company that the
      Escrow

     

    
      
         

        
        

      

      
        2

        
          

        

      

      
        
        

      

    

    Agent
      has
      custody of the Subscription Amount for the Closing, then the Escrow Agent will
      telephonically notify each Purchaser and each Purchaser shall at all times
      thereafter until the Closing have the right to demand the return of their
      portion of the Subscription Amount.

     

    1.6 Once
      the
      Escrow Agent receives a Release Notice in the form attached hereto as
Exhibit
      X
      (the
“Release
      Notice”)
      executed by the Company and each Purchaser it shall wire 100% of the aggregate
      Purchase Price amounts per the joint written instructions of the Company, net
      of
      $80,000 to cover legal and escrow agent fees to SRFF per the written
      instructions of SRFF.

    

    1.7
      Wire
      transfers to the Company shall be made pursuant to written instructions from
      the
      Company provided to the Escrow Agent on the Closing Date.

     

    1.8 Upon
      receipt by the Escrow Agent of the Release Notice from each of the Purchasers
      and the Company, the Escrow Agent shall deliver the Subscription Agreement,
      the
      certificates evidencing the Shares,
      the
      Escrow Agreement, and the opinion of counsel to the appropriate parties.

     

    1.9
       In
      the
      event the Company reasonably determines it is necessary or appropriate to reject
      the subscription of any Purchaser for whom the Escrow Agent has received
      escrowed funds and Offering Documents, the Company shall deliver written notice
      of such event to the Escrow Agent which notice shall include the reason for
      such
      rejection and the time, place and method of delivery for the return to such
      Purchaser of the escrow funds and Offering Documents delivered by such
      Subscriber. The Escrow Agent shall deliver such funds (without interest or
      deduction) and documents pursuant to such written notice.

     

    1.10 In
      the
      event the Closing Conditions, as set forth in the Memorandum and the
      Subscription Agreement, are not satisfied during the Offering Period (subject
      to
      applicable extensions), the Company shall deliver written notice executed by
      its
      duly authorized executive officer indicating that this Offering has been
      terminated and designating a termination date, and the Escrow Agent shall return
      to each Purchaser, all funds received from such Purchaser, pursuant to this
      Offering (without interest or deduction) and all documents delivered by such
      Subscriber to the Escrow Agent. 

     

    ARTICLE
      II

     

    MISCELLANEOUS

     

    2.1 No
      waiver
      or any breach of any covenant or provision herein contained shall be deemed a
      waiver of any preceding or succeeding breach thereof, or of any other covenant
      or provision herein contained. No extension of time for performance of any
      obligation or act shall be deemed an extension of the time for performance
      of
      any other obligation or act.

     

    2.2 
      All
      notices or other communications required or permitted hereunder shall be in
      writing, and shall be sent as set forth in the Subscription
      Agreement.

     

    
      
         

        
        

      

      
        3

        
          

        

      

      
        
        

      

    

    2.3 
      This
      Escrow Agreement shall be binding upon and shall inure to the benefit of the
      permitted successors and permitted assigns of the parties hereto.

     

    2.4 
      This
      Escrow Agreement is the final expression of, and contains the entire agreement
      between, the parties with respect to the subject matter hereof and supersedes
      all prior understandings with respect thereto. This Escrow Agreement may not
      be
      modified, changed, supplemented or terminated, nor may any obligations hereunder
      be waived, except by written instrument signed by the parties to be charged
      or
      by its agent duly authorized in writing or as otherwise expressly permitted
      herein.

     

    2.5 
      Whenever
      required by the context of this Escrow Agreement, the singular shall include
      the
      plural and masculine shall include the feminine. This Escrow Agreement shall
      not
      be construed as if it had been prepared by one of the parties, but rather as
      if
      all parties had prepared the same. Unless otherwise indicated, all references
      to
      Articles are to this Escrow Agreement.

     

    2.6 
      The
      parties hereto expressly agree that this Escrow Agreement shall be governed
      by,
      interpreted under and construed and enforced in accordance with the laws of
      the
      State of New York. Any action to enforce, arising out of, or relating in any
      way
      to, any provisions of this Escrow Agreement shall only be brought in a state
      or
      Federal court sitting in New York City.

     

    2.7 
      The
      Escrow Agent’s duties hereunder may be altered, amended, modified or revoked
      only by a writing signed by the Company, each Purchaser and the Escrow
      Agent.

     

    2.8 
      The
      Escrow Agent shall be obligated only for the performance of such duties as
      are
      specifically set forth herein and may rely and shall be protected in relying
      or
      refraining from acting on any instrument reasonably believed by the Escrow
      Agent
      to be genuine and to have been signed or presented by the proper party or
      parties. The Escrow Agent shall not be personally liable for any act the Escrow
      Agent may do or omit to do hereunder as the Escrow Agent while acting in good
      faith and in the absence of gross negligence, fraud and willful misconduct,
      and
      any act done or omitted by the Escrow Agent pursuant to the advice of the Escrow
      Agent’s attorneys-at-law shall be conclusive evidence of such good faith, in the
      absence of gross negligence, fraud and willful misconduct.

     

    2.9 
      The
      Escrow Agent is hereby expressly authorized to disregard any and all warnings
      given by any of the parties hereto or by any other person or corporation,
      excepting only orders or process of courts of law and is hereby expressly
      authorized to comply with and obey orders, judgments or decrees of any court.
      In
      case the Escrow Agent obeys or complies with any such order, judgment or decree,
      the Escrow Agent shall not be liable to any of the parties hereto or to any
      other person, firm or corporation by reason of such decree being subsequently
      reversed, modified, annulled, set aside, vacated or found to have been entered
      without jurisdiction.

     

    2.10 The
      Escrow Agent shall not be liable in any respect on account of the identity,
      authorization or rights of the parties executing or delivering or purporting
      to
      execute or deliver the Subscription Agreement or any documents or papers
      deposited or called for thereunder in the absence of gross negligence, fraud
      and
      willful misconduct.

     

    2.11 The
      Escrow Agent shall be entitled to employ such legal counsel and other experts
      as
      the Escrow Agent may deem necessary properly to advise the Escrow Agent in
      connection with the Escrow Agent’s duties hereunder, may rely upon the advice of
      such counsel, and may pay such counsel reasonable compensation; provided that
      the costs of such compensation shall be borne by the Escrow Agent. 

     

    
      
         

        
        

      

      
        4

        
          

        

      

      
        
        

      

    

     

     

    2.12 The
      Escrow Agent’s responsibilities as escrow agent hereunder shall terminate if the
      Escrow Agent shall resign by giving written notice to the Company and the
      Purchasers. In the event of any such resignation, the Purchasers and the Company
      shall appoint a successor Escrow Agent and the Escrow Agent shall deliver to
      such successor Escrow Agent any escrow funds and other documents held by the
      Escrow Agent.

     

    2.13 If
      the
      Escrow Agent reasonably requires other or further instruments in connection
      with
      this Escrow Agreement or obligations in respect hereto, the necessary parties
      hereto shall join in furnishing such instruments.

     

    2.14 It
      is
      understood and agreed that should any dispute arise with respect to the delivery
      and/or ownership or right of possession of the documents or the escrow funds
      held by the Escrow Agent hereunder, the Escrow Agent is authorized and directed
      in the Escrow Agent’s sole discretion (1) to retain in the Escrow Agent’s
      possession without liability to anyone all or any part of said documents or
      the
      escrow funds until such disputes shall have been settled either by mutual
      written agreement of the parties concerned by a final order, decree or judgment
      or a court of competent jurisdiction after the time for appeal has expired
      and
      no appeal has been perfected, but the Escrow Agent shall be under no duty
      whatsoever to institute or defend any such proceedings or (2) to deliver the
      escrow funds and any other property and documents held by the Escrow Agent
      hereunder to a state or Federal court having competent subject matter
      jurisdiction and located in the City of New York in accordance with the
      applicable procedure therefore

     

    2.15 The
      Company and each Purchaser agree jointly and severally to indemnify and hold
      harmless the Escrow Agent and its partners, employees, agents and
      representatives from any and all claims, liabilities, costs or expenses in
      any
      way arising from or relating to the duties or performance of the Escrow Agent
      hereunder or the transactions contemplated hereby or by the Subscription
      Agreement other than any such claim, liability, cost or expense to the extent
      the same shall have been determined by final, unappealable judgment of a court
      of competent jurisdiction to have resulted from the gross negligence, fraud
      or
      willful misconduct of the Escrow Agent.

     

    ************************

    

    

    IN
      WITNESS WHEREOF, the parties hereto have executed this Escrow Agreement as
      of
      date first written above.

     

     

    
      	
               

              MED-TECH
                SOLUTIONS, INC.

               

            	 
	
              By:
                /s/
                Mark A. McLeary

              
                

              

              Name:
                Mark A. McLeary

              Title:
                Chief Executive Officer

            	 
	
              With
                a copy to (which shall not constitute notice):

               

               

               

               

            	 
	
              ESCROW
                AGENT:

               

            	 
	
              SICHENZIA
                ROSS FRIEDMAN FERENCE LLP

               

            	 
	
              By:
                /s/
                Sichenzia
                Ross Friedman Ference LLP

              
Name:
              Sichenzia Ross Friedman Ference LLP
              Title:
                Managing Partner

            	 

    

     

    

    [REMAINDER
      OF PAGE INTENTIONALLY LEFT BLANK

    SIGNATURE
      PAGES FOR PURCHASERS FOLLOW]

    
      
         

        
        

      

      
        5

        
          

        

      

      
        
        

      

    

    [SIGNATURE
      PAGE OF PURCHASERS TO MDTU ESCROW]

     

     

    Name
      of
      Purchaser: __________________________

    Signature
      of Authorized Signatory of Purchaser:
      __________________________

    Name
      of
      Authorized Signatory: _________________________

    Title
      of
      Authorized Signatory: __________________________

    

    

    [SIGNATURE
      PAGE OF PURCHASERS FOLLOWS]

    

    
      
         

        
        

      

      
        6

        
          

        

      

      
        
        

      

    

    Exhibit
      X
      to

    Escrow
      Agreement

    RELEASE
      NOTICE

     

    The
      UNDERSIGNED, pursuant to the Escrow Agreement, dated as of March 26, 2007,
      among
      Med-Tech Solutions, Inc., the Purchasers signatories thereto and Sichenzia
      Ross
      Friedman Ference LLP, as Escrow Agent (the “Escrow
      Agreement”;
      capitalized terms used herein and not defined shall have the meaning ascribed
      to
      such terms in the Escrow Agreement), hereby notify the Escrow Agent that each
      of
      the conditions precedent to the purchase and sale of the Securities set forth
      in
      the Subscription Agreement (the “Subscription Agreement”) have been satisfied.
      The Company and the undersigned Purchaser hereby confirm that all of their
      respective representations and warranties contained in the Subscription
      Agreement remain true and correct and authorize the release by the Escrow Agent
      of the funds and documents to be released at the Closing as described in the
      Escrow Agreement. This Release Notice shall not be effective until executed
      by
      the Company and the Purchaser. 

     

    This
      Release Notice may be signed in one or more counterparts, each of which shall
      be
      deemed an original.

     

    IN
      WITNESS WHEREOF, the undersigned have caused this Release Notice to be duly
      executed and delivered as of this 26th
      day of
      March 2007.

     

     

    
      	
              MED-TECH
                SOLUTIONS, INC.

               

               

            
	
              By:
                /s/
                Mark A. McLeary

              
                

              

              Name:
                Mark A. McLeary

              Title:
                Chief Executive Officer

            

    

    

     

     

    [SIGNATURE
      PAGE OF PURCHASERS FOLLOWS]

    
      
         

        
        

      

      
        7

        
          

        

      

      
        
        

      

    

    [SIGNATURE
      PAGE OF PURCHASERS TO MDTU RELEASE]

     

     

    Name
      of
      Purchaser: __________________________

    Signature
      of Authorized Signatory of Purchaser:
      __________________________

    Name
      of
      Authorized Signatory: _________________________

    Title
      of
      Authorized Signatory: __________________________

    

    

    [SIGNATURE
      PAGE OF PURCHASERS FOLLOWS]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00121-of-00352.parquet"}]]